Abstract
The classical role of radiotherapy in the management of germ cell tumours is in the adjuvant therapy of stage I seminoma. It is interesting that here, as in other instances, the role of radiotherapy has been challenged in recent years. However, the potential uses of radiotherapy also cover the treatment of testicular intratubular germ cell neoplasia, the primary treatment of stage II seminoma, consolidation therapy for residual seminomatous masses following primary chemotherapy, for metastatic nonseminoma, and for primary CNS germ cell tumours. The latter group are the subject of articles elsewhere in this volume, and are not further discussed here.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Warde PR, Gospodarowicz MK et al. Results of a policy of surveillance in stage I testicular seminoma. Int J Radiation Oncol, Biol, Phys 1993;27:11–5
Grossfeld GD, Small EJ. Long-term side effects of treatment for testis cancer. Urol Clin North America 1998;25:503–15
Fossa SD, Horwich A, Russell JM et al. Optimal planning target volume for stage I testicular seminoma: A medical research council randomized trial .J Clin Oncol 1999;17:1146–1154
Jones WG, Fossa SD, Mead GM et al. Preliminary results of a international randomised trial of radiotherapy at two dose schedules of 20Gy versus 30Gy (at 2Gy/day) as adjuvant treatment of stage 1 seminoma testis, including morbidity and quality of life data (MRC study TE18). In this volume
Warde P, Maase Hvd, Horwich A, Gospodarowicz M, Panzarella T, Specht L. Prognostic factors for relapse in stage I seminoma managed by surveillance (meeting abstract). In: Proc Annu Meet Am Soc Clin Oncol; 1998: ASCO; 1998. p. A1188
Oliver RT, Boublikova L, Ong J. Fifteen year follow up of the Anglian Germ Cell Cancer Group adjuvant studies of carboplatin as an alternative to radiation or surveillance for stage 1 seminoma (meeting abstract). Proceedings of the American Society of Clinical Oncology 2001;20:196a
Dieckmann KP, Loy V. The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: the recent German experience. Apmis 1998;106:13–20;discussion 20–3
Dieckmann KP, Classen J, Souchon R, Loy V. Therapie der testikularen intraepitheilian Neoplasie (TIN) — eine Ubersicht auf Grunlage der evidenzbasierten Medizin (EBM) [Management of testicular intraepithelial neoplasia (TIN) — a review based on the principles of evidence-based medicine]. Wiener Klinische Wochenschrift 2001;113:7–14
von der Maase H. Editorial: Do we have a new standard of treatment for patients with seminoma stage IIA and stage IIB? Radiotherapy and Oncology 2001;59:1–3
Patterson H, Norman AR, Mitra SS et al. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Radiotherapy and Oncology 2001;59:5–11
Duchesne GM, Stenning SP, Aass N et al. Radiotherapy after chemotherapy for metastatic seminoma — a diminishing role. MRC Testicular Tumour Working Party. Eur J Cancer 1997;33:829–35
Rorth M, Jacobsen GK, Von der Maase H et al. Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer.J Clin Oncol 1991;9:1543–1548
Fossa SD, Bokemeyer C, Gerl A et al. Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 1999;85:988–97
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag London Limited
About this paper
Cite this paper
Mason, M. (2002). The Current Status of Radiotherapy in the Management of Germ Cell Tumours. In: Harnden, P., Joffe, J.K., Jones, W.G. (eds) Germ Cell Tumours V. Springer, London. https://doi.org/10.1007/978-1-4471-3281-3_51
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3281-3_51
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3283-7
Online ISBN: 978-1-4471-3281-3
eBook Packages: Springer Book Archive